论文部分内容阅读
回顾性分析我院2000-07-2005-07经肝门胆管癌手术治疗的62例患者临床资料和随访结果,总结肝门胆管癌的手术治疗体会。62例手术切除患者中行根治性切除(R0)22例,非根治性切除28例(R1,R2)。根治性切除中位生存期34个月,1、3和5年生存率分别为92.0%、40.0%和18.0%;非根治性切除中位生存期16个月,1、3和5生存率分别为83.0%、22.0%和0。另12例未完成病灶切除,9例行经肿瘤切开放置Y管内支架引流,3例行胆囊桥式肝管一十二指肠吻合,中位生存期10个月,1、3和5年生存率分别为15.0%、0和0。手术切除是治疗肝门胆管癌的有效治疗方法,根治性切除能明显改善预后。
Retrospective analysis of our hospital from 2000-07-2005-07 by hilar cholangiocarcinoma surgery in 62 patients with clinical data and follow-up results, summarize the surgical treatment of hilar cholangiocarcinoma. Totally 62 patients underwent radical resection (R0), 22 patients were non-radical resection (R1, R2). The median survival time was 34 months after radical resection, and the survival rates at 1, 3, and 5 years were 92.0%, 40.0% and 18.0% respectively. The median survival after non-radical resection was 16 months, 83.0%, 22.0% and 0. The other 12 cases were not completed resection of the lesion, 9 cases underwent Y-tube stent drainage by tumor incision, 3 cases underwent gallbladder bridge hepaticoduodenal anastomosis. The median survival time was 10 months, 1, 3 and 5 years Survival rates were 15.0%, 0 and 0 respectively. Surgical resection is an effective treatment for hilar cholangiocarcinoma, radical resection can significantly improve the prognosis.